Current Portfolio
Am-Pharma
Dutch clinical stage biopharmaceutical company developing a treatment for acute kidney injury.
Key Facts
- Sector
Life Sciences
- Country
Netherlands
- Fund
LSP 6
- Entry
2019
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.